Browse by Audience
Skip to content
Papers of the Week
Treatment of migraine with monoclonal antibodies.
Authors
PMID: 35502612.
Abstract
: In the few last years, a new family of drugs, anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs), has been developed for migraine therapy. Anti-CGRP mAbs are highly effective, but the current limited experience with their use and their high-cost warrant establishing certain rules of use.